A simple algorithm to aid in the selection of appropriate disease modifying therapies (DMTs) reduces racial disparities in patients with relapsing multiple sclerosis (MS), early new research showed.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback